Africa: Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low – and Middle-Income Countries

Africa: Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low – and Middle-Income Countries

Geneva — A pivotal moment in the fight to end AIDS — ensuring lifesaving innovation reaches those who need it most, wherever they live The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) today announced it has signed an access agreement with Gilead Sciences to procure lenacapavir, a long-acting injectable for HIV…

Read More
Africa: Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low – and Middle-Income Countries

Africa Needs About 1.3 Trillion USD Annually to Meet SDGs

Addis Ababa, — At the Fourth International Conference on Financing for Development (FfD4), African countries made a strong case for overhauling the global financial system to reflect current development realities and risks. Held in Seville, Spain, the conference ended with the adoption of a 38-page outcome document, the “Seville Commitment,” outlining voluntary steps to improve…

Read More